The legal industry has been left permanently altered from the pandemic. Five thought leaders provide their exclusive take into what these changes look like from the inside
While WTO member states have expressed general sympathy for the goal to provide broad access to vaccine technology during the pandemic, Germany continues to favour patent protection over compulsory licensing.
With strong policies in place to protect confidential information, the company was able to take swift action against an employee after becoming aware of suspicious activity
25 November 2021
From greater respect for researchers to a fresh focus on compulsory licences, IAM’s Global Leaders share their views on how the life sciences space has been changed by the quest for covid-19 vaccines
24 November 2021
Danish company makes its biggest-ever acquisition in an area where demand for assets is growing rapidly
23 November 2021
IAM’s Global Leaders speak frankly about the impact that enforced home working has had on their teams and share what they have learned
18 November 2021
In an exclusive interview with IAM, Kim Yong Rae says innovation will be discouraged if law fails to keep pace with technological change
09 November 2021
The agreement is the first granting non-exclusive and royalty free rights to sub-licensees of a covid therapeutic or vaccine
02 November 2021
Allele Therapeutics’ suits against Pfizer and Regeneron could have big implications for the extent to which platforms can monetise IP
26 October 2021
Saturday Opinion: The prospect of an international agreement on the proposed suspension of TRIPS now appears vanishingly small
23 October 2021
Diagnostic innovation buyouts drive resurgence of med-tech deal-making
19 October 2021
Unlock unlimited access to all IAM content
